Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neochem Bio SolutionsNSE:NEOCHEM +2.42%18 ROE % is 24.70% as of Mar. 2026, which is 17% above its 10-year median of 21.18. GuruFocus rates NSE:NEOCHEM with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,584 Chemicals companies, Neochem Bio Solutions ranks better than 96.84% on this metric.
Neochem Bio Solutions (NSE:NEOCHEM) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neochem Bio Solutions ROE % Chart
Neochem Bio Solutions Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
ROE %
13.33
17.96
46.86
24.40
Neochem Bio Solutions Semi-Annual Data
Mar23
Mar24
Mar25
Sep25
Mar26
ROE %
0.00
0.00
69.89
42.19
24.70
NSE:NEOCHEM vs LIN, SHW, ECL: ROE % Comparison
For the Specialty Chemicals subindustry, Neochem Bio Solutions's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neochem Bio Solutions ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Neochem Bio Solutions's ROE % distribution charts can be found below:
* The bar in red indicates where Neochem Bio Solutions's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Neochem Bio Solutions (NSE:NEOCHEM) has a ROE % of 24.70% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Neochem Bio Solutions and its competitors. This is 17% above median its historical median of 21.18. Over the past decade, Neochem Bio Solutions' ROE % has ranged from 13.33 to 46.86. According to the industry distribution chart, Neochem Bio Solutions ranks #50 out of 1584 companies in the Chemicals industry, placing it in the top 3.2%.
Is Neochem Bio Solutions' ROE % too high?
Neochem Bio Solutions' current ROE % of 24.70% is 17% above median its 10-year median of 21.18. Over the past 10 years, this metric has ranged from a low of 13.33 to a high of 46.86. The Chemicals industry median ROE % is 5.38. Neochem Bio Solutions' value of 24.70% is 359.5% above this industry median. Based on the distribution chart, Neochem Bio Solutions ranks #50 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Neochem Bio Solutions has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Neochem Bio Solutions' ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Neochem Bio Solutions ranks #50 out of 1584 companies for ROE %. This places Neochem Bio Solutions in the top 3% of its industry — outperforming the majority of peers. The industry median ROE % is 5.38. Neochem Bio Solutions' value of 24.70% is 359.5% above this benchmark. Historically, Neochem Bio Solutions' own ROE % has ranged from 13.33 to 46.86 over the past decade. While the company's 10-year median is 21.18 vs. the industry median of 5.38, Neochem Bio Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.38, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neochem Bio Solutions's current ROE % of 24.70% is 359.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Neochem Bio Solutions and its competitors. For the Chemicals industry, the median ROE % is 5.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neochem Bio Solutions's current ROE % is 24.70%, which is 17% above median its own 10-year median of 21.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neochem Bio Solutions stock overvalued right now?
Neochem Bio Solutions (NSE:NEOCHEM) has a current ROE % of 24.70%. The current ROE % is 24.70%, which is 17% above median its 10-year median of 21.18 and 359.5% above the Chemicals industry median of 5.38. Neochem Bio Solutions' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Neochem Bio Solutions (NSE:NEOCHEM), the current ROE % is 24.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neochem Bio Solutions Ltd is a specialty performance chemical company. Its primary product segments such as Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
18GF Score
Get the complete analysis for NSE:NEOCHEM
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEOCHEM has been successfully added to your 
